Protocol Ledger

NCT06250062 · Phase II · COMPLETED

A Clinical Study of JS005 in Patients With Ankylosing Spondylitis

Interventional Phase II clinical trial protocol NCT06250062 sponsored by Shanghai Junshi Bioscience Co in Immunology, Rheumatology, and Dermatology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-01-13 Enrollment: 265 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06250062
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)265 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06250062
Protocol FieldVerified Registry Value
NCT IdentifierNCT06250062
Consolidated Lead SponsorShanghai Junshi Bioscience Co
Therapeutic Condition CohortImmunology, Rheumatology, and Dermatology
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment265 participants (ACTUAL)
Registered Start Date2024-01-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI